[Federal Register Volume 81, Number 12 (Wednesday, January 20, 2016)]
[Notices]
[Pages 3205-3206]
[FR Doc No: 2016-01130]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Sunshine Act Meeting

    Notice is hereby given, pursuant to the provisions of the
Government in the Sunshine Act, Pub. L. 94-409, that the Securities and
Exchange Commission will hold a Closed Meeting on Thursday, January 21,
2016 at 2:00 p.m.
    Commissioners, Counsel to the Commissioners, the Secretary to the
Commission, and recording secretaries will attend the Closed Meeting.
Certain staff members who have an interest in the matters also may be
present.
    The General Counsel of the Commission, or her designee, has
certified that, in her opinion, one or more of the exemptions set forth
in 5 U.S.C. 552b(c)(3), (5), (7), 9(B) and (10) and 17 CFR
200.402(a)(3), (5), (7), 9(ii) and (10), permit consideration of the
scheduled matter at the Closed Meeting.
    Commissioner Piwowar, as duty officer, voted to consider the items
listed for the Closed Meeting in closed session.
    The subject matter of the Closed Meeting will be:

Institution and settlement of injunctive actions;
Institution and settlement of administrative proceedings;
Consideration of amicus participation;
Post-argument discussion; and
Other matters relating to enforcement proceedings.
    At times, changes in Commission priorities require alterations in
the scheduling of meeting items.
    For further information and to ascertain what, if any, matters have
been added, deleted or postponed, please

contact the Office of the Secretary at<PHONE_NUMBER>.

     Dated: January 14, 2016.
Brent J. Fields,
Secretary.
[FR Doc. 2016-01130 Filed 1-15-16; 4:15 pm]
BILLING CODE 8011-01-P


Agency.</tertiary-title></titles><dates><year>1999</year></dates><urls><
/urls></record></EndNote> (Bryceland, 1999)

	Subchronic Oral (90 day oral)	Laboratory Rat-female

Rattus norvegicus

TGAI

98.6	NOAEL = 125 mg/kg	Neurological dysfunction	40215601

  ADDIN EN.CITE
<EndNote><Author>Bryceland</Author><Year>1999</Year><RecNum>9</Rec
Num><DisplayText>(Bryceland,
1999)</DisplayText><record><rec-number>9</rec-number><foreign-keys><key
app="EN" db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">9</key><key
app="ENWeb"
db-id="RcJqaQrtmCQAAFU55fA">369</key></foreign-keys><ref-type name="EPA
Document">51</ref-type><contributors><authors><author>Andrew
Bryceland</author></authors></contributors><titles><title>EFED Response
to 24 C Esfenvalerate PC Code No:  109303; Case No. 066625; Submission
No. S566161; DP Barcode D258253</title><tertiary-title>Environmental
Fate and Effects Division.  Office of Pesticide Programs.  United States
Environmental Protection
Agency.</tertiary-title></titles><dates><year>1999</year></dates><urls><
/urls></record></EndNote> (Bryceland, 1999)

Laboratory Rat

Rattus norvegicus

TGAI

98.8	Parental Systemic:  LOAEC=75 ppm ai (4.21 mg/kg-bw/day, male and
female)

NOAEC =  < 75 ppm ai

Offspring:

LOAEC=100 ppm ai (7.18 mg/kg-bw/day, female)

NOAEC = 75 ppm ai (5.56 mg/kg-bw/day, female)	43489001

Acceptable

  ADDIN EN.CITE
<EndNote><Author>Borges</Author><Year>2008</Year><RecNum>1</RecNum
><DisplayText>(Borges,
2008)</DisplayText><record><rec-number>1</rec-number><foreign-keys><key
app="EN" db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">1</key><key
app="ENWeb"
db-id="RcJqaQrtmCQAAFU55fA">362</key></foreign-keys><ref-type name="EPA
Document">51</ref-type><contributors><authors><author>Borges,
Shannon</author><author>White, Katrina</author><author>Thurman,
Nelson</author></authors></contributors><titles><title>Risks of
Esfenvalerate Use to Federally Threatened California Red-Legged Frog
(Rana aurora draytonii).  Pesticide Effects
Determination</title><secondary-title>February 19,
2008</secondary-title><tertiary-title>Environmental Fate and Effects
Division, Office of Pesticide Programs. United States Environmental
Protection
Agency</tertiary-title></titles><periodical><full-title>February 19,
2008</full-title></periodical><keywords><keyword>Esfenvalerate</keyword>
</keywords><dates><year>2008</year><pub-dates><date>February 19,
2008</date></pub-dates></dates><pub-location>Washington,
D.C.</pub-location><publisher>Government Printing Office.  Washington,
D.C.</publisher>Endangered Species
Assessment<urls><related-urls><url>http://www.epa.gov/espp/litst
atus/effects/redleg-frog/index.html</url></related-urls></urls><access-d
ate>June 19, 2009</access-date><modified-date>February 19,
2008</modified-date></record></EndNote> (Borges et al., 2008)

	Birds

Acute Oral	Bobwhite Quail (Colinus virginianus)

Age= 23 wks

bw=168-215 g

	SS-isomer	TGAI

98.6	NOAEL <125 mg/kg-bw

LD50 = 381 mg/kg-bw (125– positive infinity)

NOAEL/LOAEL = 125/250 mg/kg-bw

Nominal	Sublethal Effects

Mortality

Mortality	41698401

(1991) Acceptable, DER 06/12/1991	No NOAEL available for sublethal
effects; however, no mortality occurred at 125 mg/kg-bw, the lowest test
level.  Sublethal effects observed include: ruffled appearance, lower
limb weakness, muscular fasciculations,  hyper-excitability, loss of
coordination, depression and reduced reaction to external stimuli,
reduction in food consumption, and head twitching.  Many birds recovered
over time.  Slope not available.  Mixed in water and corn oil.

Acute Oral	Bobwhite Quail (Colinus virginianus)

	All isomers	TGAI

97.6	LD50 >2000 mg/kg-bw

NOEC/LOEC = 125/250 mg/kg-bw

nominal	No mortality

Sublethal effects	41891909 (1991) Acceptable

09/25/1991	Sublethal effects include hyperexcitability, agitation, lower
limb weakness, and excessive scratching.

Acute Dietary	Bobwhite Quail (Colinus virginianus)

Age = 10 days

bw = 15.9 ±0.4 g	SS-isomer	TGAI

98.6	LC50 >5620 mg/kg-diet

NOAEL/LOAEL = 1000/1780 mg/kg-diet

Reduction in body weight	41637803 (1990) Acceptable

8/9/1991	Sublethal effects include body weight reduction, lethargy,
ruffled appearance,

Dietary concentrations were not adjusted for purity of test substance.
Group body weights were measured rather than individual body weights.

Acute Dietary	Mallard Duck (Anas platyrhynchos)

Age = 10 day

bw=280.2±6.4g

	SS-isomer	TGAI

98.6	LC50 = 4894 mg/kg-diet (1780 ppm - + infinity)

NOAEL = <562 mg/kg-diet

NOAEL/LOAEL = 562/1000 mg/kg-diet	Mortality

Decreased body weight

Mortality	41637802 (1990) Acceptable, DER 08/9/1991	Dose related
reduction in body weight at the 562, 1000, and 1780 mg/kg during the
exposure period when compared to control and loss of body weight at the
3160 and 5620 ppm concentrations.  There was no apparent effect on feed
consumption at the 1000 through 5620 ppm concentrations for this same
period.  Temperatures in brooding chambers were not in accordance with
SEP.  Slope not available.

Acute Dietary	Mallard Duck (Anas platyrhynchos)

Age = 10 days

	All isomers

	TGAI

97.6	LC50 = >5000 mg/kg-diet (1780 - + infinity)

NOAEL/LOAEL = 312.5/625 mg/kg-diet

No NOAEL	Mortality

Mortality

Body weight gain	41891911 (1991)

Acceptable

09/19/1991	Sublethal effects include lethargy, ruffled appearance,
depression, loss of coordination, reduced reaction to external stimuli,
prostate posture, loss of righting reflex, hyperexcitability, and
convulsions.  Decreased body weight gain and food consumption at all
test concentrations.

Acute Dietary	Bobwhite quail (Colinus virginianus)

Age = 10 days	All isomers	TGAI

97.6	LC50  >5000 mg/kg-diet

NOEC/LOEL = 1250/2500 mg/kg-diet

Nominal	No mortality

Reductions in body weight gain	41891910 (1991)

Acceptable

09/19/1991	No mortality observed.  Sublethal effects include lethargy,
ruffled appearance, wing drop, depression, loss of coordination, reduced
reaction to sound and movement.

Terrestrial Invertebrates

Acute Contact

	Honey Bee Apis mellifera L.	SS-isomer	TGAI

98.6	48-hr LD50 = 0.017( 0.0125 – 0.025) µg/bee

NOAEL/ LOAEL= 0.00625/0.0125 µg/bee	Mortality	41698402 (1990)

Acceptable

07/01/1991	Liquid

Acute Contact	Honey Bee Apis mellifera 	All isomers	TGAI

NS	48-hr LD50 = 0.408 µg/bee	Mortality	246165 or 86066 (1981)

Acceptable

NS	Applied as dust.

Acute Contact	Honey Bee Apis mellifera	All isomers	TEP	Time not
specified in DER LD50 = 0.41 units not specified	Mortality	246165 or
86066 (1981)

Acceptable

12/11/1981	Applied as dust.

Acute Field	Honey Bee Apis mellifera	All isomers	TEP

2.4 lb EC

	86064 (1981)

Acceptable

12/11/1981	Field Study.  Bees caged with treated alfalfa foliage for
various time frames and mortality was evaluated after 24-hrs.  0.4 lb
ai/acre caused 100% mortality.

Acute Field	Honey Bee Apis mellifera	All isomers	TEP

2.4 lb/gal EC

	89065 (1981)

Acceptable

12/11/1981	Field study where two bee colonies next to blooming alfalfa
field were evaluated after fenvalerate treatment.

Table B4.  Summary of terrestrial toxicity data submitted for
esfenvalerate and fenvalerate that may only be used qualitatively or are
unacceptable/invalid.

Study Type

	Test Species	Isomers	TGAI or TEP	Toxicity Endpoint

(95% C.I.)

Slope

Measured/ nominal	Effect	MRID (Year)

Classification, DER date or source	Comments

Birds

One Generation	Bobwhite Quail (Colinus virginianus)

	All	TGAI

Not-specified

	00037111 (1980)

Supplemental   ADDIN EN.CITE
<EndNote><Author>Bryceland</Author><Year>1999</Year><RecNum>9</Rec
Num><DisplayText>(Bryceland,
1999)</DisplayText><record><rec-number>9</rec-number><foreign-keys><key
app="EN" db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">9</key><key
app="ENWeb"
db-id="RcJqaQrtmCQAAFU55fA">369</key></foreign-keys><ref-type name="EPA
Document">51</ref-type><contributors><authors><author>Andrew
Bryceland</author></authors></contributors><titles><title>EFED Response
to 24 C Esfenvalerate PC Code No:  109303; Case No. 066625; Submission
No. S566161; DP Barcode D258253</title><tertiary-title>Environmental
Fate and Effects Division.  Office of Pesticide Programs.  United States
Environmental Protection
Agency.</tertiary-title></titles><dates><year>1999</year></dates><urls><
/urls></record></EndNote> (Bryceland, 1999) , DER 08/25/1980
Reported to be pydrin and SD43775 Technical.  Percent ai not specified.
Only 3 test concentrations. Exposure to fenvalerate may result in
cracking of eggs; however, the effect was not great enough to be
statistically detectable. There was also some question over the amount
of fenvalerate contained in the highest treatment level (125 ppm), which
actually contained, based on samples tested, 60 – 85 ppm. An estimate
of the LOAEC and NOAEC may be determined to be 25 and <25 ppm,
respectively.  Eggshell cracking observed at all dosages, 25, 75, and
125 ppm   ADDIN EN.CITE
<EndNote><Author>Bryceland</Author><Year>1999</Year><RecNum>9</Rec
Num><DisplayText>(Bryceland,
1999)</DisplayText><record><rec-number>9</rec-number><foreign-keys><key
app="EN" db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">9</key><key
app="ENWeb"
db-id="RcJqaQrtmCQAAFU55fA">369</key></foreign-keys><ref-type name="EPA
Document">51</ref-type><contributors><authors><author>Andrew
Bryceland</author></authors></contributors><titles><title>EFED Response
to 24 C Esfenvalerate PC Code No:  109303; Case No. 066625; Submission
No. S566161; DP Barcode D258253</title><tertiary-title>Environmental
Fate and Effects Division.  Office of Pesticide Programs.  United States
Environmental Protection
Agency.</tertiary-title></titles><dates><year>1999</year></dates><urls><
/urls></record></EndNote> (Bryceland, 1999) .

One generation	Bobwhite Quail	All	TGAI

96%

	Accession No. 963-85 (1975)

Supplemental

NS	Data indicated that test birds were subject to diet deficiency during
the study.

One generation	Mallard Duck (Anas platyrhynchos)

Age =

Male bw  = Female bw =

	all	TGAI

Not specified

	00037112 (1980)

Supplemental   ADDIN EN.CITE
<EndNote><Author>Bryceland</Author><Year>1999</Year><RecNum>9</Rec
Num><DisplayText>(Bryceland,
1999)</DisplayText><record><rec-number>9</rec-number><foreign-keys><key
app="EN" db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">9</key><key
app="ENWeb"
db-id="RcJqaQrtmCQAAFU55fA">369</key></foreign-keys><ref-type name="EPA
Document">51</ref-type><contributors><authors><author>Andrew
Bryceland</author></authors></contributors><titles><title>EFED Response
to 24 C Esfenvalerate PC Code No:  109303; Case No. 066625; Submission
No. S566161; DP Barcode D258253</title><tertiary-title>Environmental
Fate and Effects Division.  Office of Pesticide Programs.  United States
Environmental Protection
Agency.</tertiary-title></titles><dates><year>1999</year></dates><urls><
/urls></record></EndNote> (Bryceland, 1999)

DER 08/25/1980	Reported to be pydrin and SD43775 Technical.  Percent
a.i. not specified.  Eggshell cracking observed at all dosages, 25, 75,
and 125 ppm   ADDIN EN.CITE
<EndNote><Author>Bryceland</Author><Year>1999</Year><RecNum>9</Rec
Num><DisplayText>(Bryceland,
1999)</DisplayText><record><rec-number>9</rec-number><foreign-keys><key
app="EN" db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">9</key><key
app="ENWeb"
db-id="RcJqaQrtmCQAAFU55fA">369</key></foreign-keys><ref-type name="EPA
Document">51</ref-type><contributors><authors><author>Andrew
Bryceland</author></authors></contributors><titles><title>EFED Response
to 24 C Esfenvalerate PC Code No:  109303; Case No. 066625; Submission
No. S566161; DP Barcode D258253</title><tertiary-title>Environmental
Fate and Effects Division.  Office of Pesticide Programs.  United States
Environmental Protection
Agency.</tertiary-title></titles><dates><year>1999</year></dates><urls><
/urls></record></EndNote> (Bryceland, 1999) .

Avian Reproduction	Mallard Duck

Anas platyrhynchos

	All isomers	TGAI

97%

	121827 (1975)

Supplemental

NS	2 page DER. (Acc No. 963-85)

Supplemental because of exposure being lower than that predicted in
field.

Avian Reproduction	Bobwhite Quail

Age = 9 mos

	All isomers	TGAI

96%	NA	NA	109832 (1975)

Supplemental-qualitative

NS	Mean eggshell thickness was slightly below the normal range (0.2-0.22
mm) in controls and treatment groups.  Also percent of eggs cracked
(0.6-2.0%) was high for all groups.

Acute Field	Honey Bee Apis mellifera	All isomers	TEP

2.4 lb/gal EC

	89065 (1981)

Acceptable

12/11/1981	Field study where two bee colonies next to blooming alfalfa
field were evaluated after fenvalerate treatment.

Appendix   SEQ Appendix \* ALPHABETIC  C :  Summary of products with
multiple active ingredients

Table C1.  Summary of products containing esfenvalerate and other active
ingredients that may be used outdoors

Registration #	Name	Indoor/ Outdoor	Percent a.i.	Active Ingredient
Outside uses

239-2679	ORTHO ROACH, ANT AND SPIDER KILLER	Indoor and Outdoor	0.3	MGK
264	spray, spot treatment - ant trails, around doors, and windows,
garbage cans, wherever pests enter homes, under porches, patios,
surfaces that flies and mosquitoes land on

Esfenvalerate

	Prallethrin

	498-167	SPRAYPAK ANT & ROACH KILLER FORMULA 2	Indoor and Outdoor	0.06
d-trans-Chrysanthemum monocarboxylic ester of
dl-2-allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one	Spray, spot treatment
for flies and mosquitoes.  Around doors and windows, patios, surfaces
where insects may land

	0.05	Esfenvalerate

0.2	MGK 264

0.12	Piperonyl butoxide

	498-177	SPRAYPAK INSTUTIONAL ANT AND ROACH RESIDUAL SPRAY	Indoor and
Outdoor	0.25	MGK 264	Spray, spot treatment for flies and mosquitoes.
Around doors and windows, patios, surfaces where insects may land

	0.03	Prallethrin

0.05	Esfenvalerate

	506-176	TAT ROACH & ANT SPRAY WITH RESIDUAL ACTION 2491	Indoor and
Outdoor	0.06	d-trans-Chrysanthemum monocarboxylic ester of
dl-2-allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one	Outdoors to control
flies and mosquitoes.  Outside surfaces of window and doorframes and
other areas where pests may be present. Spray dark corners, localized
resting areas, under eaves of porches, patios, and garages.

	0.05	Esfenvalerate

0.12	Piperonyl butoxide

0.2	MGK 264

	1021-1594	EVERCIDE RESIDUAL PRESSURIZED SPRAY 2523	Indoor and Outdoor
0.06	d-trans-Chrysanthemum monocarboxylic ester of
dl-2-allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one	Outdoors to control
flies and mosquitoes - Spray outside surfaces of window and door frames
as well as other areas where these pests may enter the home.  Spray dark
corners and localized resting areas such as porches, patios, garages,
and under eaves.

	0.2	MGK 264

0.12	Piperonyl butoxide

0.05	Esfenvalerate

	1021-1601	EVERCIDE RESIDUAL ANT & ROACH SPRAY 2543	Indoor and Outdoor
0.25	MGK 264	Use only outdoors as an aid in reducing annoyance from
flies and mosquitoes.  Spray outside surfaces of window and door frames
as well as other areas where these pests may enter the home.  Also spray
dark corners and localized resting areas of porches patios, garages and
where insects congregate.

	0.03	Prallethrin

0.05	Esfenvalerate

	1021-1613	EVERCIDE WASP AND HORNET SPRAY 2577	Outdoor	0.2	Tetramethrin
spray hornet, wasp, and yellow jacket nests; ants and spiders:  spray
electric service boxes, water meter boxes, telephone boxes, along
foundation, vents sills, and ledges, ant trails, runways, and hills.  Do
not spray foliage.

	0.031	Esfenvalerate

	1021-1635	EVERCIDE TOTAL RELEASE FOGGER 2602	Indoor and Outdoor	0.167
MGK 264	For use outdoors with Fire Ant Housing to kill fire ants.
Activate the mound by disturbing, cover with bucket, canopy, box),
engage lever mechanism to discharge aerosol.  Leave undisturbed for 15
minutes. 1 unit treats 6000 cubic ft.  Max for fire ants is 6 oz.

	0.05	Pyrethrins

0.1	Esfenvalerate

0.1	Piperonyl butoxide

	1021-1691	EVERCIDE CRAWLING INSECT KILLER 2548	Indoor and Outdoor	0.3
MGK 264	Outdoors to control flies and mosquitoes - Spray outside
surfaces of window and door frames as well as other areas where these
pests may enter the home.  Spray dark corners and localized resting
areas such as porches, patios, garages, and under eaves.

	0.05	Esfenvalerate

0.03	Prallethrin

	1021-1697	EVERCIDE ROACH & ANT SPRAY 2622	Indoor and Outdoor	0.045
d-trans-Chrysanthemum monocarboxylic ester of
dl-2-allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one	Spot treatment, crack
and crevice treatment - Camp sites, decks, dog houses, drive-ins,
dumpsters, garbage cans, gazebos, outdoor eating establishments, patios,
porches, stadiums, verandas

	0.05	Esfenvalerate

0.25	MGK 264

	1021-1764	EVERCIDE WASP & HORNET SPRAY 26011	Indoor and Outdoor	0.167
MGK 264	Wasp, hornet, and yellow jacket nests. Spray nest until
saturated.

	0.1	Piperonyl butoxide

0.1	Esfenvalerate

0.05	Pyrethrins

	1021-1787	EVERCIDE O.B. RTU 28101	Indoor and outdoor	0.05	Esfenvalerate
Outdoors to control flies and mosquitoes - Spray outside surfaces of
window and door frames as well as other areas where these pests may
enter the home.  Spray dark corners and localized resting areas such as
porches, patios, garages, and under eaves. Repeat every 2 weeks as
needed.  Ant trails

	0.03	Prallethrin

	1021-1810	PYROCIDE FALCON 7452	Indoor and Outdoor	0.1	Pyriproxyfen
around structures to control insects

	0.2	Esfenvalerate

3	MGK 264

2	Piperonyl butoxide

1	Pyrethrins

	1021-1852	EVERCIDE WASP & HORNET SPRAY 26012	Outdoor	0.025	Pyrethrins
Kill insects. Spray nest until saturated.  2 second burst directly on
insect.

	0.05	Esfenvalerate

0.084	MGK 264

0.05	Piperonyl butoxide

	11715-186 (transferred from 2724-583)	SPEER RESIDUAL PRESSURIZED SPRAY
Outdoor and Indoor	0.065	d-trans-Chrysanthemum monocarboxylic ester of
dl-2-allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one	Outdoors to control
flies and mosquitoes - Spray outside surfaces of window and door frames
as well as other areas where these pests may enter the home.  Spray dark
corners and localized resting areas such as porches, patios, garages,
and under eaves.

	0.05	Esfenvalerate

0.12	Piperonyl butoxide

0.2	MGK 264

0.6	Pyriproxyfen

0.04	Prallethrin

	11715-320 (transferred from 2724-673)	SPEER ANT AND ROACH KILLER II
Indoor and Outdoor	0.25	MGK 264	Outdoors to control flies and mosquitoes
- Spray outside surfaces of window and door frames as well as other
areas where these pests may enter the home.  Spray dark corners and
localized resting areas such as porches, patios, garages, and under
eaves.

	0.05	Esfenvalerate

0.03	Prallethrin

	8848-86	BLACK JACK ROACH & ANT KILLER VI	Indoor and Outdoor	0.03
Prallethrin	Outdoors to control flies and mosquitoes - Spray outside
surfaces of window and door frames as well as other areas where these
pests may enter the home.  Spray dark corners and localized resting
areas such as porches, patios, garages, and under eaves. Repeat every 2
weeks as needed.  Ant trails

	0.25	MGK 264

0.05	Esfenvalerate

	10807-191	MISTY FIRE ANT INJECTOR SPRAY II	Outdoor	0.2	Tetramethrin
Yards, parks, woodlands, playgrounds, and golf courses.  Insert injector
rod into mound, spray for 5 seconds for each 6 in diameter mound

	0.1	Esfenvalerate

	28293-196	UNICORN HOUSE AND CARPET SPRAY #6	Indoor and outdoor	0.065
d-trans-Chrysanthemum monocarboxylic ester of
dl-2-allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one	Outdoors to control
flies and mosquitoes - Spray outside surfaces of window and door frames
as well as other areas where these pests may enter the home.  Spray dark
corners and localized resting areas such as porches, patios, garages,
and under eaves

	0.2	MGK 264

0.05	Esfenvalerate

0.12	Piperonyl butoxide

	44446-65	CS 101 ROACH & ANT SPRAY	Indoor and Outdoor 	0.25	MGK 264
Garbage cans and dumpsters- spot  treatment, crack and crevice, ant
trails, Outdoors to control flies and mosquitoes - Spray outside
surfaces of window and door frames as well as other areas where these
pests may enter the home.  Spray dark corners and localized resting
areas such as porches, patios, garages, and under eaves

	0.05	Esfenvalerate

0.03	Prallethrin

	45385-93	CTX/CYBER BLAST	Outdoor 	0.25	MGK 264	Residual spray outdoors
for flies and mosquitoes.  Repeat treatments as necessary.

	0.05	Esfenvalerate

0.03	Prallethrin

	68543-17	BENGAL ROACH & ANT SPRAY IV	Indoor and Outdoor 	0.3	MGK 264
Spot treatment, crack and crevice, residual spray for flies and
mosquitoes

Table C2.  Summary of products containing esfenvalerate and other active
ingredients that may be used indoors only

Registration #	Name	Use Site	Percent a.i.	Active Ingredient

239-2624	HI-POWER INDOOR INSECT FOGGER FORMULA V	Indoor	0.167	MGK 264

	0.1	Piperonyl butoxide

	0.1	Esfenvalerate

	0.05	Pyrethrins

498-186	CHAMPION SPRAYON INDOOR INSECT FOGGER FORMULA 4	Indoor	1	MGK 264

	0.1	Esfenvalerate

	0.2	Tetramethrin

506-181	TAT TOTAL RELEASE WATER BASED FOGGER	Indoor	1	MGK 264

Tetramethrin

Esfenvalerate

706-105	MULTI-USE INSECTICIDE FOGGER	Indoor	0.1	Esfenvalerate

	0.05	Pyrethrins

	0.167	MGK 264

	0.1	Piperonyl butoxide

769-584	R&M FLEA & TICK FOGGER #1	Indoor	0.2	Tetramethrin

	0.1	Esfenvalerate

1021-1648	EVERCIDE TOTAL RELEASE AEROSOL 2604	Indoor	1	MGK 264

	0.1	Esfenvalerate

	0.2	Tetramethrin

1021-1656	EVERCIDE NYLAR TOTAL RELEASE AEROSOL 2644	Indoor	0.1
Esfenvalerate

	0.04	Prallethrin

	0.6	Pyriproxyfen

1021-1674	EVERCIDE TOTAL RELEASE AEROSOL 2614	Indoor	0.167	MGK 264

	0.05	Pyrethrins

	0.1	Pyriproxyfen

	0.1	Esfenvalerate

	0.1	Piperonyl butoxide

1021-1676	EVERCIDE TOTAL RELEASE AEROSOL 2615	Indoor	0.167	MGK 264

	0.1	Piperonyl butoxide

	0.1	Esfenvalerate

	0.6	Pyriproxyfen

	0.05	Pyrethrins

1021-1755	EVERCIDE RESIDUAL ROACH AND ANT SPRAY 27693	Indoor	0.05
Imiprothrin

	0.25	MGK 264

	0.05	Esfenvalerate

1021-1756	EVERCIDE RESIDUAL ROACH AND ANT SPRAY 27692	Indoors	0.075
Imiprothrin

	0.075	Esfenvalerate

	0.375	MGK 264

1021-1757	EVERCIDE RESIDUAL ROACH AND ANT SPRAY 27691	Indoors	0.1
Imiprothrin

	0.5	MGK 264

	0.1	Esfenvalerate

1021-1762	EVERCIDE RESIDUAL ROACH & ANT SPRAY 27891	Indoor	0.1
Imiprothrin

	0.5	MGK 264

	0.05	Esfenvalerate

1021-1827	EVERCIDE HOME DEFENSE 28452	Indoors	0.025	Imiprothrin

	0.025	Esfenvalerate

9444-143	CB-305 FOGGER

0.3	d-trans-Chrysanthemum monocarboxylic ester of
dl-2-allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one

	0.05	Esfenvalerate

9444-144	CB-405 FOGGER	Indoor	0.167	MGK 264

	0.1	Piperonyl butoxide

	0.05	Pyrethrins

	0.1	Esfenvalerate

9444-145	CB FOGGER IV	Indoor	0.2	Tetramethrin

	0.1	Esfenvalerate

9444-166	CB-405 FOGGER WB	Indoor	0.167	MGK 264

	0.05	Pyrethrins

	0.1	Esfenvalerate

	0.1	Piperonyl butoxide

9444-168	COUNTRY VET ROACH EMBARGO WITH GROWTH INHIBITOR	Indoor	0.1
Esfenvalerate

	0.6	Pyriproxyfen

	0.04	Prallethrin

11623-44	TOTAL RELEASE FOGGER III	Indoor	1	MGK 264

	0.1	Esfenvalerate

	0.2	Tetramethrin

28293-192	UNICORN HOUSE AND CARPET SPRAY #5	Indoor	0.065
d-trans-Chrysanthemum monocarboxylic ester of
dl-2-allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one

	0.05	Esfenvalerate

	0.12	Piperonyl butoxide

	0.2	MGK 264

11715-188 (transferred from 2724-584)	SPI TOTAL RELEASE AEROSOL FOGGER
II	 Indoor	0.3	d-trans-Chrysanthemum monocarboxylic ester of
dl-2-allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one

	0.05	Esfenvalerate

11715-275 (transferred from 2724-647)	SPEER-IT FOGGER II TOTAL RELEASE
AEROSOL	Indoor	0.167	MGK 264

	0.1	Piperonyl butoxide

	0.05	Pyrethrins

	0.1	Esfenvalerate

11715-308 (transferred from 2724-662)	SPEER TOTAL RELEASE AEROSOL II
WITH NYLAR	Indoor	0.167	MGK 264

	0.1	Pyriproxyfen

	0.1	Piperonyl butoxide

	0.05	Pyrethrins

	0.1	Esfenvalerate

2724-664	SPEER TOTAL RELEASE AEROSOL III WITH NLAR	Indoor	0.1
Esfenvalerate

	0.6	Pyriproxyfen

	0.04	Prallethrin

11715-320 (transferred from 2724-673)	SPEER ANT AND ROACH KILLER II
Indoor and Outdoor	0.25	MGK 264

11715-323 (transferred from 2724-676)	SPEER-IT FOGGER IV TOTAL RELEASE
AEROSOL	Indoor	1	MGK 264

	0.2	Tetramethrin

	0.1	Esfenvalerate

Table C3.  Summary of manufacturing use products containing
esfenvalerate and other active ingredients

Registration #	Name	Percent a.i.	Active Ingredient

	1021-1575	EVERCIDE INTERMEDIATE 2491	3.01	d-trans-Chrysanthemum
monocarboxylic ester of
dl-2-allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one

10	MGK 264

6	Piperonyl butoxide

2.5	Esfenvalerate

1021-1627	EVERCIDE INTERMEDIATE 2531	1.5	d-trans-Chrysanthemum
monocarboxylic ester of
dl-2-allyl-4-hydroxy-3-methyl-2-cyclopenten-1-one

8.33	MGK 264

1.67	Esfenvalerate

1021-1634	EVERCIDE CONCENTRATE 2601	6.43	MGK 264

3.86	Piperonyl butoxide

1.92	Pyrethrins

3.85	Esfenvalerate

1021-1647	EVERCIDE CONCENTRATE 2603	27.78	MGK 264

5.61	Tetramethrin

2.78	Esfenvalerate

1021-1652	EVERCIDE INTERMEDIATE 2666	10.01	Tetramethrin

1.57	Esfenvalerate

1021-1655	EVERCIDE CONCENTRATE 2625	5	Esfenvalerate

2	Prallethrin

1021-1692	EVERCIDE CONCENTRATE 2547	12	MGK 264

2	Esfenvalerate

1.2	Prallethrin

1021-1754	EVERCIDE INTERMEDIATE 2769	2.5	Imiprothrin

2.5	Esfenvalerate

12.5	MGK 264

1021-1763	EVERCIDE INTERMEDIATE 2789	2.5	Imiprothrin

1.25	Esfenvalerate

12.5	MGK 264

1021-1788	EVERCIDE CONCENTRATE 2810	2.5	Esfenvalerate

1.5	Prallethrin

1021-1826	EVERCIDE EMULSIFIABLE CONCENTRATE 2845 MUP	0.425	Imiprothrin

0.425	Esfenvalerate

1021-1690	EVERCIDE CONCENTRATE 2595	12.5	MGK 264

2.5	Esfenvalerate

1.5	Prallethrin

Appendix   SEQ Appendix \* ALPHABETIC  D .  ECOSAR (version 1.0)
Results for 4-chloro-alpha-(1-methylethyl)-benzeneacetic acid (CPIA)

SMILES : CC(C)C(C(=O)O)c1ccc(CL)cc1

MOL FOR: C11 H13 CL1 O2

MOL WT : 212.68

Log Kow: 3.40  (KowWin estimate)

Melt Pt:

Wat Sol: 116.8 mg/L  (WskowWin estimate)

ECOSAR v1.00 Class(es) Found

------------------------------

Neutral Organics-acid

Predicted

ECOSAR Class                 Organism            Duration  End Pt   mg/L
(ppm)

==========================  ==================  ========  ======
==========

--> Acid moeity found: Predicted values multiplied by 10

Neutral Organics-acid      : Fish                96-hr     LC50
96.265

Neutral Organics-acid      : Fish                14-day    LC50
99.554

Neutral Organics-acid      : Daphnid             48-hr     LC50
66.757

Neutral Organics-acid      : Green Algae         96-hr     EC50
58.181

Neutral Organics-acid      : Fish                30-day    ChV
11.015

Neutral Organics-acid      : Daphnid                       ChV
9.660

Neutral Organics-acid      : Green Algae                   ChV
28.073

Neutral Organics-acid      : Fish  (SW)          96-hr     LC50
120.335 *

Neutral Organics-acid      : Mysid Shrimp        96-hr     LC50
35.383

Neutral Organics-acid      : Fish  (SW)                    ChV
31.333

Neutral Organics-acid      : Mysid Shrimp (SW)             ChV
2.020

Neutral Organics-acid      : Earthworm           14-day    LC50
2647.435 *

 Note:  * = asterisk designates: Chemical may not be soluble

        enough to measure this predicted effect.

Neutral Organics:

----------------

  For Fish LC50 (96-h), Daphnid LC50, Mysid: If the log Kow is greater

than 5.0, or if the compound is solid and the LC50 exceeds the water

solubility by 10X, no effects at saturation are predicted.

  For Fish LC50 (14-day) and Earthworm LC50: If the log Kow is greater

than 6.0, or if the compound is solid and the LC50 exceeds the water

solubility by 10X, no effects at saturation are predicted.

  For Green Algae Acute Toxicity Values: If the log Kow of the chemical
is

greater than 6.4, or if the compound is solid and the EC50 exceeds the
water

solubility by 10X, no effects at saturation are predicted for these
endpoints.

 For All Chronic Toxicity Values: If the log Kow of the chemical is
greater

than 8.0, or if the compound is solid and the ChV exceeds the water
solubility

by 10X, no effects at saturation are predicted for these endpoints.

ECOSAR v1.00 SAR Limitations:

----------------------------

Maximum LogKow: 5.0 (Fish 96-hr LC50; Daphnid LC50, Mysid LC50)

Maximum LogKow: 6.0 (Fish 14-day LC50; Earthworm LC50)

Maximum LogKow: 6.4 (Green Algae EC50)

Maximum LogKow: 8.0 (ChV)

Maximum Mol Wt: 1000

------------------------------------------------------------------------
------

 See Page 18 of the SAP meeting minutes   ADDIN EN.CITE
<EndNote><Author>Bucher</Author><Year>2009</Year><RecNum>244</RecN
um><DisplayText>(Bucher and Bailey,
2009)</DisplayText><record><rec-number>244</rec-number><foreign-keys><ke
y app="EN"
db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">244</key></foreign-keys><re
f-type name="EPA
Memo">2</ref-type><contributors><authors><author>Bucher, John
R.</author><author>Bailey, J.
E.</author></authors></contributors><titles><title>A Set of Scientific
Issues Being Considered by the Environmental Protection Agency
Regarding:  Evaluation of the Common Mechanism of Action of Pyrethroid
Pesticides.  SAP Minutes No. 2009-07</title></titles><edition>United
States Environmental Protection
Agency</edition><dates><year>2009</year><pub-dates><date>September 9,
2009</date></pub-dates></dates><urls><related-urls><url>http://www.epa.g
ov/scipoly/sap/meetings/2009/june/061609minutes.pdf</url></related-urls>
</urls><access-date>October 28,
2009</access-date></record></EndNote> (Bucher and Bailey, 2009) .

 In previous risk assessments, a chronic fish study on the fathead
minnow yielded a no observable adverse effect concentration (NOAEC) of
0.21 µg/L and is reported as acceptable;  however, re-evaluation of the
study indicated that the study is unacceptable (Accession Number 97000)
 ADDIN EN.CITE   ADDIN EN.CITE.DATA ́  (Borges et al. 2008; Bryceland
1999) .  The test concentration was not constant over time (e.g., within
20% of initial concentrations) and not measurable (e.g., concentrations
were below the method detection limit) at many times during the study.
Additionally, the concentration of the test solution was doubled on day
63 and the lowest observable adverse effects concentration (LOAEC) was
higher than the 96-hr LC50 for the same species (MRID 41215201).

 When the SS-isomer is used in aquatic toxicology studies it will also
undergo isomerization when placed in water.  The only way to ensure
exposure to one isomer to be able to compare the toxicity of the
different isomers to aquatic organisms would be to inject the organism.

h¾

␃ം׆Ā⇀愂Ȥ摧獠

G

'

F

G

 hô(

  hô(

  hô(

 hô(

 hô(

B*

B*

B*

B*

h

 h

h

h¾

h¾

h¾

hób

h¾

h¾

☊଀ᵆ㜀$␸䠀$摧瑠¨

摧ᕈy

摧ⲁ`

&

5

j

k

n

„

yt

%

&

`

d

g

j

k

k

I

H

I

J

K

M

®

¯

°

±

³

Î

Ï

Ð

Ñ

Ò

Ó

7I

J

¯

°

Ï

Ï

Ð

kd

 h

ô

ô

ô

ô

ô

ô

ô

ô

ô

ô

  h

 h

ô

  h

h;;

hŠ

hŠ

 h

œÿ$	\

hŠ

hŠ

hŠ

摧形

h

hb_

h

h

hk

摧形

hÝj

hÝj

hf

hÝj

hÝj

@

hÝj

hÝj

	@

	@

	@

	@

	@

@

*	 h

*	 h

  h

 h

h

 h

  h

  h

  h

  h

h

  h

  h

  h

 h

  h

h

h

  h

  h

  h

  h

  h

  h

  h

  h

  h

਀&䘋-摧渨r	㜀$␸䠀$摧渨r

h

ž

$

<

hÏz

hÏz

hÏz

hÏz

hÏz

yt|T

  h¤x

 h¤x

  h¤x

gd¤x

ô

ô

ô

ô

ô

ô

 h

؀Ĥ摧Ꮓ°

摧愮X

摧呼

 h|T

 h|T

 h|T

 h|T

 h|T

 h|T

#

,

5

;

D

F

G

b

e

«

¬

Ã

×

Ø

[

 hÅ

hÅ

hÅ

*	 hÅ

hÅ

-

# h²u

 h²u

# h²u

h²u

  h²u

 h²u

  h²u

kd

h

  h²u

h²u

 h²u

  h²u

 h²u

h

h

  h

  h²u

 h²u

 h²u

# h²u

  h²u

  h

 h²u

  h

kd

 h²u

# h²u

  h²u

 h²u

# h²u

  h²u

 h²u

# h²u

  h²u

 h²u

3

  h²u

 h²u

 h²u

$

3

¬

%

É

Ê

 h

 h

}

~

…

Œ

•

–

—

¢

±

Ã

Æ

Ë

Ñ

ÿ

Œ

“

”

–

—

±

Â

Ñ

Û

Ý

ß

â

æ

ç

ö

6ÿ

Ff

@

ô

@

ô

@

ô

@

ô

@

ô

kd^

@

ô

@

ô

@

ô

@

ô

@

ô

@

ô

@

ô

@

ô

愀Ĥ摧啛!Ԁ

@

ô

@

ô

@

ô

@

ô

ĀrЀr摧዁ Ѐr摧噛OЀr摧䊃~Ѐr摧㛛Ø᠀ ADDIN EN.CITE
<EndNote><Author>Barile</Author><Year>2004</Year><RecNum>41</RecNu
m><DisplayText>(Barile,
2004)</DisplayText><record><rec-number>41</rec-number><foreign-keys><key
app="EN" db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">41</key><key
app="ENWeb"
db-id="RcJqaQrtmCQAAFU55fA">400</key></foreign-keys><ref-type
name="Book">6</ref-type><contributors><authors><author>Barile, Frank
A</author></authors></contributors><titles><title>Clinical Toxicology:
Principles and
Mechanisms</title></titles><dates><year>2004</year></dates><pub-location
>Boca Raton, FL</pub-location><publisher>CRC
Press</publisher><urls></urls></record></EndNote> (Barile, 2004)
.   In potentiation, one agent is relatively nontoxic.  Some references
indicate that for synergism to occur both chemicals must have cytotoxic
activity and the sum of effects of the two chemicals combined is greater
than the individual effects (e.g., “1+2>3”)   ADDIN EN.CITE
<EndNote><Author>Lewis</Author><Year>1998</Year><RecNum>38</RecNum
><DisplayText>(Lewis,
1998)</DisplayText><record><rec-number>38</rec-number><foreign-keys><key
app="EN" db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">38</key><key
app="ENWeb"
db-id="RcJqaQrtmCQAAFU55fA">397</key></foreign-keys><ref-type
name="Dictionary">52</ref-type><contributors><authors><author>Robert A.
Lewis</author></authors><secondary-authors><author>Robert A.
Lewis</author></secondary-authors></contributors><titles><title>Lewis&ap
os; Dictionary of
Toxicology</title></titles><dates><year>1998</year></dates><pub-location
>Boca Raton</pub-location><publisher>Lewis
Publishers</publisher><urls></urls></record></EndNote> (Lewis,
1998) .  Often synergism and potentiation are used interchangeably
ADDIN EN.CITE
<EndNote><Author>Lewis</Author><Year>1998</Year><RecNum>38</RecNum
><DisplayText>(Lewis,
1998)</DisplayText><record><rec-number>38</rec-number><foreign-keys><key
app="EN" db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">38</key><key
app="ENWeb"
db-id="RcJqaQrtmCQAAFU55fA">397</key></foreign-keys><ref-type
name="Dictionary">52</ref-type><contributors><authors><author>Robert A.
Lewis</author></authors><secondary-authors><author>Robert A.
Lewis</author></secondary-authors></contributors><titles><title>Lewis&ap
os; Dictionary of
Toxicology</title></titles><dates><year>1998</year></dates><pub-location
>Boca Raton</pub-location><publisher>Lewis
Publishers</publisher><urls></urls></record></EndNote> (Lewis,
1998) .

 Piperonyl butoxide initially results in inhibition followed by
stimulation/induction of microsomal enzymes   ADDIN EN.CITE
<EndNote><Author>Hodgson</Author><Year>2001</Year><RecNum>40</RecN
um><DisplayText>(Hodgson and Smart,
2001)</DisplayText><record><rec-number>40</rec-number><foreign-keys><key
app="EN" db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">40</key><key
app="ENWeb"
db-id="RcJqaQrtmCQAAFU55fA">399</key></foreign-keys><ref-type
name="Edited Book">28</ref-type><contributors><authors><author>Hodgson,
Ernest</author><author>Smart, Robert
C</author></authors></contributors><titles><title>Introduction to
Biochemcial
Toxicology</title></titles><edition>Third</edition><dates><year>2001</ye
ar></dates><pub-location>New
York</pub-location><publisher>Wiley-Interscience</publisher><urls></urls
></record></EndNote> (Hodgson and Smart, 2001) .  It is used in
pharmacological experiments to compare therapeutical or toxicological
effects of drugs before and after metabolism.  It is known to induce
CYP2B1 and 1A2 at moderate doses and 1A1 at high does levels   ADDIN
EN.CITE
<EndNote><Author>Hodgson</Author><Year>2001</Year><RecNum>40</RecN
um><DisplayText>(Hodgson and Smart,
2001)</DisplayText><record><rec-number>40</rec-number><foreign-keys><key
app="EN" db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">40</key><key
app="ENWeb"
db-id="RcJqaQrtmCQAAFU55fA">399</key></foreign-keys><ref-type
name="Edited Book">28</ref-type><contributors><authors><author>Hodgson,
Ernest</author><author>Smart, Robert
C</author></authors></contributors><titles><title>Introduction to
Biochemcial
Toxicology</title></titles><edition>Third</edition><dates><year>2001</ye
ar></dates><pub-location>New
York</pub-location><publisher>Wiley-Interscience</publisher><urls></urls
></record></EndNote> (Hodgson and Smart, 2001) .  The mechanism
of induction was shown to be independent of the aryl hydrocarbon
receptor (AhR) using AhR-knockout mice   ADDIN EN.CITE
<EndNote><Author>Hodgson</Author><Year>2001</Year><RecNum>40</RecN
um><DisplayText>(Hodgson and Smart,
2001)</DisplayText><record><rec-number>40</rec-number><foreign-keys><key
app="EN" db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">40</key><key
app="ENWeb"
db-id="RcJqaQrtmCQAAFU55fA">399</key></foreign-keys><ref-type
name="Edited Book">28</ref-type><contributors><authors><author>Hodgson,
Ernest</author><author>Smart, Robert
C</author></authors></contributors><titles><title>Introduction to
Biochemcial
Toxicology</title></titles><edition>Third</edition><dates><year>2001</ye
ar></dates><pub-location>New
York</pub-location><publisher>Wiley-Interscience</publisher><urls></urls
></record></EndNote> (Hodgson and Smart, 2001) .

 Pyrethroids may be excreted as glycine, sulfate, glucuronide, or
glucoside conjugates   ADDIN EN.CITE
<EndNote><Author>Gibly</Author><Year>2001</Year><RecNum>39</RecNum
><DisplayText>(Gibly and Sullivan Jr.,
2001)</DisplayText><record><rec-number>39</rec-number><foreign-keys><key
app="EN" db-id="s0xer2w2o0xwx3e0a0tx0sz3zradttw529er">39</key><key
app="ENWeb"
db-id="RcJqaQrtmCQAAFU55fA">398</key></foreign-keys><ref-type name="Book
Section">5</ref-type><contributors><authors><author>Gibly, Raquel
L.</author><author>Sullivan Jr., John
B.</author></authors><secondary-authors><author>Sullivan Jr., John
B.</author><author>Krieger, Gary
R.</author></secondary-authors></contributors><titles><title>Chapter
103. Pyrethrins</title><secondary-title>Clinical Principles of
Environmental
Health</secondary-title></titles><dates><year>2001</year></dates><pub-lo
cation>Philadelphia, PA</pub-location><publisher>Lippincott Williams
& Wilkins</publisher><urls></urls></record></EndNote> (Gibly
and Sullivan Jr., 2001) .

 http://www.epa.gov/oppefed1/general/databasesdescription.htm#eiis

 All chronic studies should be completed using the TGAI.

 The species tested should also have TEP data available (e.g., Rainbow
trout or bluegill sunfish).

 The study using the TEP should examine toxicity to the most sensitive
species tested with the TGAI.

 The species tested should be the species most sensitive to the TGAI,
e.g., Daphnia magna.

 The study using the TEP should examine toxicity to the most sensitive
species tested with the TGAI.

 All aquatic chronic studies should be conducted using the TGAI.

 PAGE

Page   PAGE  8  of 109

 *

*

Ingestion

Residues in Aquatic Organisms

Ingestion

Birds / Amphibians

Wet/dry deposition

Root uptake

Atmospheric transport

Dermal uptake/Ingestion

Ingestion

Ingestion

Ingestion

Ingestion

Soil / Ant Mounds

Exposure

Media

Mammals

Runoff

Terrestrial/riparian plants

grasses/forbs, fruit, seeds (trees, shrubs)

Habitat integrity

Reduction in primary productivity

Reduced cover

Community change

Food chain

Reduction in prey

Individual organisms

Reduced survival

Reduced growth

Reduced reproduction

Terrestrial

insects

Birds / Terrestrial-phase amphibians / Reptiles / Mammals /
Invertebrates

Spray drift

Direct

application

Esfenvalerate applied to use site

All isomers are considered a stressor.

Attribute

Change

Receptors

Source

Stressor(s)


[Federal Register: June 5, 2009 (Volume 74, Number 107)]
[Notices]
[Page 27062]
[DOCID:fr05jn09-91]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Pipeline and Hazardous Materials Safety Administration

[Docket ID PHMSA-2009-0157]

Pipeline Safety: Government/Industry Pipeline Research and
Development Forum

AGENCY: Pipeline and Hazardous Materials Safety Administration (PHMSA),
DOT.

ACTION: Notice of forum.

-----------------------------------------------------------------------

SUMMARY: PHMSA executes a collaborative, coordinated, competitive and
co-funded research and development (R&D) program with the pipeline
industry and other Federal and State regulators. PHMSA periodically
holds a Pipeline R&D Forum to generate recommendations on the future
R&D required in addressing mutual challenges. Specifically, this forum
will bring government and industry pipeline stakeholders together for
the following purposes:
    (1) Develop recommendations to address the technical gaps &
challenges for future R&D
    (2) Identify both short and long term research objectives for
liquid/gas transmission and gas distribution pipelines;
    (3) Quantify technical details on identified technical gaps so
solicited research is addressing the need effectively; and
    (4) Provide details on the ultimate research goals so appropriate
end users are factored into project scopes.

DATES: The forum will be held starting on June 24, 2009, at 8 a.m. and
concluding on June 25, 2009, at 4 p.m. Pre-Registration is available
now and until June 19, 2009, to obtain a name tag to this free public
event. Onsite registration will be available for the public on the
morning of June 24, 2009. Please note that a Web cast will not be
available for the forum. However, presentations will be available on
the R&D Program Web site (http://primis.phmsa.dot.gov/rd/workshops.htm)
shortly after the forum.
    Please visit http://primis.phmsa.dot.gov/meetings/
MtgHome.mtg?mtg=59 for more information on the agenda and reservations.

ADDRESSES: The workshop will be held at the Marriott Crystal City, 1999
Jefferson Davis Highway, Arlington, VA 22202, Phone: 1-800-228-9290, or
Phone: 1-703-413-5500. The Marriott Web page for this hotel is found
at: http://www.marriott.com/hotels/travel/wascc-crystal-city-marriott-
at-reagan-national-airport/ or http://www.marriott.com/default.mi and
by typing DCA into the City or Airport Code Search.
    Hotel reservations must be made on or before June 9, 2009, to
receive a rate of $209 for the nights of Tuesday, June 23 and
Wednesday, June 24. Mention ``USDOT R&D Forum'' when you make your
reservations to receive this rate. Please call the Marriott for more
information on the Americans with Disabilities Act amenities at this
location.

FOR FURTHER INFORMATION CONTACT: Robert Smith at<PHONE_NUMBER>, or by
e-mail at<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:
    Registration: Members of the public may attend this free forum. To
help assure that adequate space is provided, all attendees are
encouraged to pre-register for the forum at http://
primis.phmsa.dot.gov/meetings/MtgHome.mtg?mtg=59. Hotel reservations
must be made by contacting the hotel directly.
    Information on Services for Individuals with Disabilities: For
information on facilities or services for individuals with
disabilities, or to request special assistance at the meeting, please
contact Robert Smith or the Marriott by June 23, 2009.

    Issued in Washington, DC, on May 29, 2009.
Jeffrey D. Wiese,
Associate Administrator for Pipeline Safety.
[FR Doc. E9-13180 Filed 6-4-09; 8:45 am]

BILLING CODE 4910-60-P